Presidents Pick

As we begin 2026, I am honored to welcome you to a new year and a new chapter for the Oligonucleotide Therapeutics Society. The start of the year is a natural moment for reflection on how far our field has come, and on the ...

Encapsulating decades of research, this article by Dr. Sudhir Agrawal, the 2022 OTS Lifetime Achievement Award recipient, explores the transformative potential of RNA-based therapies through the lens of over 30 years of learnings. The article highlights the remarkable progress made in the field, emphasizing ...

Another stellar review article summarizing the field now published in Nucleic Acid Therapeutics. The review in Nucleic Acid Therapeutics by Jillian Belgrad and colleagues discusses the significant progress and future potential of nucleic acid-based therapies (NATs). It highlights the historical milestones, including the approval of ...

True to the vision of OTS, we worked with our journal publisher, Mary Ann Liebert publishers, Inc., through our BOD Committees to compile a list of important open-access Nucleic Acid Therapeutics (NAT) publications relating to the development of safe oligonucleotides. Finding high-quality publications to guide ...

The OTS Annual Meeting 2023 in Barcelona was a showcase of excellent science and a demonstration of how far our field has advanced over the past nineteen years. Congratulations to our LAA winners Dr. Sudhir Agrawal and Dr. Cy Stein, our other award winners, our ...

During the 2022 OTS annual meeting in Phoenix it was easy to listen to the talks announcing successful clinical trial results and assume that obviously favorable data were becoming routine. Willeke van Roon-Mom, Chantal Ferguson, and Annemieke Aartsma-Rus have just published a commentary (Nucleic ...

Researchers involved in developing oligonucleotide therapeutics have always been known for picking difficult problems related to difficult diseases. SOD1-ALS is a deadly neurodegenerative disease caused by a mutation in the SOD1 protein. Because the disease is due to the SOD1 mutation, it is possible to ...

PMID: 36881759 DOI: 10.1093/nar/gkad067 Writing a good review article is not easy. A good Review not only summarizes the literature, it also provides an expert perspective so that the reader has enough insight to sort the important from the unimportant. That means that the expert authors, who ...

The journal RNA, the official publication of the RNA society, has always been one of my favorite journals. RNA’s April issue is devoted to Perspective articles related to nucleic acids therapeutics. Michelle Hastings and Adrian Krainer deserve our thanks as they took on the task ...

I would like to thank everyone who attended OTS 2022, whether in person or virtual. Special thanks to Keith Gagnon and Annemieke Aartsma-Rus and the entire organizing group for putting together such a great schedule of talks. Masad Damha coordinated the intricate network of award ...